AR and posterior cortical atrophy: However, the prognosis for PCa patients with metastatic and castration-resistant diseases was poor, and novel approaches were explored to improve patients’ outcomes, including androgen receptor signaling inhibitor (ARSI) (5), and immunotherapy (6, 7).